Efficacy of Live Attenuated and Inactivated Influenza Vaccines in Schoolchildren and Their Unvaccinated Contacts in Novgorod, Russia

Journal of Infectious Diseases

Volumn 168, Issue 4, 1993, Pages 881-887

  Rudenko, L G ^a,b,c,d   Slepushkin, A N ^a,b,c,d   Monto, A S ^a,b,c,c,d   Kendal, A P ^a,b,c,d   Grigorieva, E P ^a,b,c,d   Burtseva, E P ^a,b,c,d   Rekstin, A R ^a,b,c,d   Beljaev, A L ^a,b,c,d   Bragina, V E ^a,b,c,d   Cox, N ^a,b,c,c,d   Ghendon, Y Z ^a,b,c,d   Alexandrova, G I Alexandrova ^a,b,c,d  

^a D I IVANOVSKY INSTITUTE OF VIROLOGY   (Russian Federation)

^b UNIVERSITY OF MICHIGAN   (United States)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d WHO REGIONAL OFFICE FOR EUROPE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; INFLUENZA VACCINATION; INFLUENZA VIRUS A; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SUBCUTANEOUS DRUG ADMINISTRATION; USSR; VIRUS TRANSMISSION;

ADOLESCENT; CHILD; COMPARATIVE STUDY; HEMAGGLUTINATION INHIBITION TESTS; HUMAN; INFLUENZA; INFLUENZA A VIRUS, HUMAN; INFLUENZA VACCINE; PLACEBOS; PREVALENCE; REGRESSION ANALYSIS; RESPIRATORY TRACT DISEASES; RUSSIA; SPECIES SPECIFICITY; VACCINES, ATTENUATED;

EID: 0027214695     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/168.4.881     Document Type: Article

References (21)

1. Centers for Disease Control, Prevention and control of influenza: recommendations of the Immunization Practices Advisory Committee (ACIP), MMWR 1992; 41(RR-9): 1-17.
2. Dowdle WR, Millar JD, Schonberger LB, Ennis FA, LaMontagne JR, Influenza immunization policies and practices in Japan, J Infect Dis 1980; 141: 258-64.
3. Slepushkin AN, Bobyleva TK, Russina AE, Vitkina BS, Ellendorn NE, Zhdanov VM, Evaluation of the effectiveness of large-scale vaccination against influenza in the USSR, Bull WHO 1967; 36: 385-95.
4. World Health Organization, Progress in the development of influenza vaccines: memorandum from a WHO meeting, Bull WHO 1987; 65: 289-93.
5. Alexandrova GL, Polezhaev FL, Budilovski GN, Garmashova LM, Topuria NA, Egorov AY, Recombinant cold-adapted attenuated influenza A vaccines for use in children: reactogenicity and antigenic activity of cold-adapted recombinants and analysis of isolates from the vaccines, Infect Immun 1984; 44: 734-9.
6. Committee on Standard Serologic Procedures in Influenza Studies, An aggultination-inhibition test proposed as a standard reference in influenza diagnostic studies, J Immunol 1950; 65: 347-53.
7. Sears SD, Clements ML, Betts RF, Maassab HF, Murphy BR, Snyder MH, Comparison of live attenuated HI N I and H3N2 cold-adapted and avian-human influenza A reassortant viruses and inactivated virus vaccine in adults, J Infect Dis 1988; 158: 1209-18.
8. Centers for Disease Control, Influenza vaccine composition, Recommendation for the 1989-90 season, MMWR 1989; 38: 183-5.
9. Monto AS, Kioumehr F, The Tecumseh study of respiratory illness, IX, Occurrence of influenza in the community 1966-1971, Am J Epidemiol 1975; 102: 553-63.
10. Glezen WP, Serious morbidity and mortality associated with influenza epidemics, Epidemiol Rev 1982; 2: 26-44.
11. Monto AS, Koopman JS, Longini JM, Tecumseh study of illness, XIII, Influenza infection and disease 1976-1981, Am J Epidemiol 1985; 121: 811-22.
12. Monto AS, Maassab HF, Use of influenza vaccine in non-high risk population, Dev Bioi Stand 1977; 39: 329-35.
13. Elveback LR, Fox JP, Ackerman E, Langworth A, Boyde M, Gatewood L, An influenza simulation model for immunization studies, Am J Epidemiol 1976; 103: 153.
14. Monto AS, Davenport FM, Napier JA, Francis T Jr, Modification ofan influenza outbreak in Tecumseh, Michigan, by vaccination ofschool children, J Infect Dis 1970; 122: 16-25.
15. Clover RD, Crawford S, Glezen WP, Taber LH, Matson CC, Couch RB, Comparison of heterotypic protection against influenza A/Taiwan/86 (H IN I) by attenuated and inactivated vaccines to A/Chilel 83-like viruses, J Infect Dis 1991; 163: 300-4.
16. Gorse GJ, Belshe RB, Munn NJ, Superiority of live attenuated compared to inactivated influenza A virus vaccines in older, chronically ill adults, Chest 1991; 100: 977-84.
17. Slepushkin AN, Obrosova-Serova NP, Burtseva EL Comparison of live attenuated and inactivated influenza vaccines in schoolchildren in Russia, I, Safety and efficacy in two Moscow schools, 1987. Vaccine 1993; 11: 323-8.
18. Oya A, Nerome K, Experiences with mass vaccination of young age groups with inactivated vaccines, In: Kendal AP, Patriarca PA, eds, Options for the control of influenza, Proceedings ofa Viratek-UCLA Symposium, New York: Alan R Liss, 1986: 183-92.
19. Clements ML, Tierney EL, Murphy BR, Response of seronegative and seropositive adult volunteers to live attenuated cold-adapted reassortant influenza A virus vaccine, J Clin Microbiol 1985; 21: 997-9.
20. Johnson PR, Feldman S, Thompson JM, Mahoney JD, Wright PF, Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted and inactivated vaccines, J Infect Dis 1986; 154: 121-6.
21. Keitel WA, Couch RB, Cate TR, Six HR, Baxter BD, Cold recombinant influenza B/Texas/l/84 vaccine virus (CRB87): attenuation, immunogenicity, and efficacy against homotypic challenge, J Infect Dis 1990; 161: 22-6.